repositioning


Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.

repositioning

changing a BRAND'S design, physical properties or the identity it projects to alter the ‘position’ of the brand in a market. See MARKET POSITIONING.
References in periodicals archive ?
With around 2,000 Phase II and Phase III failed pipeline candidates typically sitting idle in a typical pharma drug library, drug repositioning may resurrect abandoned R&D programs.
The repositioning of the fund's portfolio is expected to commence in early 2012, and is intended to increase the attractiveness of the fund's common shares and narrow the fund's trading discount by simplifying its investment mandate to a preferred-focused strategy.
More details on the repositioning can be found in the JQC Portfolio Repositioning Overview by clicking here: http://www.
Levin is currently repositioning the retail portion of the Gale Company's Princeton Forrestal Village, a mixed-use facility in Princeton, New Jersey.
Drug repositioning has several advantages over traditional discovery-reduced cost, risk and time to market-compared with traditional discovery, providing an attractive prospect for Big Pharma, scrambling to fill pipelines in an increasingly harsh market environment.
Under its drug repositioning agreement with Pfizer, Gene Logic has been seeking new therapeutic applications for selected drug candidates that are no longer in active development.
Now completed, we will introduce the comprehensive repositioning plan that when implemented will assure Reckson Platinum Mile's status as the most prestigious business location in Westchester County.
Now, however, to refuel product pipelines and improve profit margins, many companies are turning to low-risk strategies such as drug repositioning.
The 320,000 s/f Office building has been renamed Advance at Southgate and will undergo a complete repositioning.
com/reports/c59322) has announced the addition of Drug Repositioning Strategies: Innovative Strategies to Boost Pipeline Productivity to their offering.
As we grow our brand in New York and key markets in the US, Affinia will continue to take the long view towards repositioning for greater returns and a stronger brand.
Drug repositioning is regarded as the pharma industry's solution to falling R&D productivity and weakening product pipelines, successfully repositioned drugs such as raloxifene (Evista; Lilly), thalidomide (Thalomid; Celegene), (Exubera;Pfizer/Nektar) have enabled innovative companies to adopt lower risk strategies to optimize product pipelines.